agilon health, inc. (AGL) SEC Filings & Earnings Calls

Membership decline of 10% YoY due to disciplined contracting and market exits; may limit top-line growth.

“Total members decreased to 549,000 from 614,000 a year ago.”

Dependence on Medicare Advantage and ACO model; regulatory changes could impact reimbursement.

“Medicare Advantage members 437,000; ACO model members 112,000.”

Securities class action and derivative lawsuits

“In February and March 2024, three putative securities class action lawsuits were filed and subsequently consolidated as In re agilon health, inc. Securities Litigation... The Consolidated Securities Matter seeks compensatory damages, judgment interest, attorney’s fees and costs, and other unspecified equitable and/or injunctive relief.” · word for word

Concentration risk with payors

“Payor A and Payor B each represented 20% and 25% of total revenues for the three months ended June 30, 2026, respectively.”

Debt covenant compliance risk

“The Credit Facility contains customary covenants including, among other things, limitations on restricted payments... Failure to meet any of these covenants could result in an event of default under the Credit Agreement.”

Cash flow negative from operations

“Net cash provided by (used in) operating activities $(33,569) for the six months ended June 30, 2026.”

Key person risk from CTO departure; mitigated by consulting agreement.

“CTO departure with transition consulting through December 31, 2026.”

Litigation risk from securities class actions

“Multiple securities class action and derivative lawsuits are ongoing, alleging misstatements about financial guidance, medical margin, and growth strategy.”

Membership decline

“Members decreased to 426,300 from 438,000 at year-end 2025, indicating potential loss of market share or contract attrition.”

Debt covenant compliance risk

“Credit facility requires minimum $50M cash daily and positive EBITDA for two consecutive trailing four-quarter periods to make certain payments.”

Membership decline due to market exits and payor exits may limit future revenue growth.

“Total members decreased 11% YoY to 536,000; Medicare Advantage members down 13%.”

Cost trend reserved at 7.4% for Medicare Advantage members could pressure margins if actual trend exceeds.

“Medical margin includes cost trend for Medicare Advantage members reserved at 7.4%.” · word for word

CEO transition risk; new leadership may not achieve stock price targets for PSU vesting.

“PSU vesting requires stock price targets of $50, $100, $150; current stock price not disclosed.”

Profitability Pressure from Cost Trends and Utilization

“Profitability was pressured by lower risk adjustment revenue, strategic market exits, prior year development, continued elevated cost trends and utilization in certain categories.” · word for word

CEO Transition and Leadership Instability

“On July 29, 2025, Mr. Steven Sell resigned as the Chief Executive Officer and President of the Company and from the Company’s Board of Directors, effective immediately.” · word for word

Dependence on Medicare Advantage Payor Contracts

“The Company’s ability to maintain and secure additional contracts with Medicare Advantage payors on favorable terms, if at all.” · word for word

Medical Expenses Exceeding Revenues

“medical expenses incurred on behalf of members may exceed revenues received” · word for word

History of Net Losses

“the Company’s history of net losses and the expectation that the Company's expenses will increase in the future” · word for word

Reverse stock split indicates low stock price and potential non-compliance with listing standards.

“Stockholders approved a reverse stock split at a ratio of 1-for-25.”

Transformation execution risk

“Transformation initiatives referenced; forward-looking statements caution.”

Medical cost pressure

“Medical costs, Medical Margin mentioned in forward-looking statements.”

NYSE Delisting Risk

“On November 5, 2025, we received written notice from the NYSE informing us that we are no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of our common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 4, 2025.” · word for word

History of Losses and Uncertain Profitability

“We have incurred significant net losses in prior years and have a substantial accumulated deficit. We expect that our expenses will increase substantially in the foreseeable future and our losses may continue.” · word for word

Medical Cost Overrun Risk

“Amounts of medical expenses that are incurred on behalf of our members may exceed the amount of medical revenues we receive to provide care for such members.” · word for word

Payor Concentration Risk

“We contract with a limited number of payors, and our membership is dependent on such payors attracting and retaining members.” · word for word

NYSE delisting risk

“on November 5, 2025, the Company received a written notification from the NYSE notifying the Company that it had failed to comply with the minimum bid price requirement because the bid price for the Company's common stock over a period of 30 consecutive business days prior to such date had closed below the minimum $1.00 per share requirement.” · word for word

Reverse stock split execution risk

“There can be no assurance that the Reverse Stock Split will achieve any of the above desired result of increasing the market price for the Company's common stock or regaining compliance with the minimum bid price requirement.” · word for word

Liquidity risk increased due to reduced revolver and minimum cash covenant; profitability condition for dividends indicates weak earnings trajectory.

“reduced revolver from $100M to $90M; $50M minimum cash; dividend restriction tied to positive EBITDA”

Delisting risk from NYSE non-compliance; reverse stock split may not be approved or effective.

“NYSE notice of non-compliance with continued listing standard.”

Forward-looking statements highlight risks including history of net losses, dependence on Medicare Advantage contracts, and physician partner relationships.

“Risk factors section in the press release.”

Negative medical margin

“Medical services expense $1,489,479 thousand exceeds medical services revenue $1,432,437 thousand for Q3 2025.”

Operating cash flow negative

“Net cash used in operating activities $85,226 thousand for 9M 2025.”

Securities litigation

“Consolidated Securities Matter and Derivative Matters lawsuits filed against the company.”

Customer concentration

“Payor A, B, C, and E each represent 11-17% of total revenue for Q3 2025.”